Analyst Ratings for Rexnord Corp. (RXN)Updated: 2017-07-27
Rexnord Corp. (NYSE:RXN) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, RXN was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 5 gave it a buy rating, 1 issued an overweight rating, 1 issued a hold rating, 1 issued an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Investment analysts gave a few price targets for RXN. The most optimistic analyst gave a price target of 27, which equates to a potential upside of 15.88 percent. The minimum price target given was 18, implying a possible loss of -22.75 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -3.7 percent. The average change in earnings estimates over the last 90 days is -7.14 percent. Meanwhile, fiscal year estimates have been revised downwards by -1.17 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -4.89 percent in FY estimates.
People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 1 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 1 analysts that revised their FY estimates downwards.
The growth rate of RXN's earnings is estimated by analysts to be 88.49 percent. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of RXN is 0.41.
RXN has traded between a high of 25.00 and a low of 15.80 over the past year. Today's price is 47.47 percent above the 52-week low, and 6.8 percent lower than its 52-week high. RXN has a price/earnings ratio of 35.85. Investors typically compare the P/E ratio to a company's peers in the industry. The RXN value stock report compares RXN to some of its peers using value stock charts. The market cap of RXN is $2.48 billion. RXN's next earnings release will be on 0000-00-00, which is days away.